Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | OMS721 | - | - | - | - | [3] 64 64, 66, 109 |
| 2 | OMS721 (narsoplimab) | [1] Narsoplimab Narsoplimab | [1] D11531
D11531
| [1] MASP2 MASP2 💬 | [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | [2] 66 66, 222 |
| 3 | OMS721 100 mg/ml Injection solution, OMS00620646, OMS620646, MASP-2 Antibody | [1] Narsoplimab Narsoplimab | [1] D11531
D11531
| [1] MASP2 MASP2 💬 | [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | [2] 64 64, 109 |
| 4 | OMS721 185 mg/ml Injection solution, OMS00620646, OMS620646, MASP-2 Antibody | [1] Narsoplimab Narsoplimab | [1] D11531
D11531
| [1] MASP2 MASP2 💬 | [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | [2] 64 64, 109 |
| 5 | OMS721 Drug Product 185 mg/mL | - | - | - | - | [1] 109 109 |